๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus

โœ Scribed by Monika Misra


Book ID
119876950
Publisher
Pharmaceutical Press
Year
2012
Tongue
English
Weight
337 KB
Volume
65
Category
Article
ISSN
2042-7158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The SGLT2 Inhibitor Empagliflozin for th
โœ McGill, Janet B. ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 617 KB

## Introduction The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence, which has paralleled the rise in obesity, has strained the healthcare system and prompted the search for therapies that not only effective